Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload

No abstract is available for this paper.

• Publication year

  2000

• Venue

  HYPERTENSION

• Publication date

  2000-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.36.3.355PMID 10988264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.

  1998cited by this paper
• Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload.

  1998cited by this paper
• Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

  1998cited by this paper
• Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload.

  1998cited by this paper
• Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

  1998cited by this paper
• BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.

  1997cited by this paper
• Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.

  1997cited by this paper
• Endothelin-1 Is Involved in Stretch-Induced Early Activation of B-Type Natriuretic Peptide Gene Expression in Atrial but Not in Ventricular Myocytes

  1997cited by this paper
• Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms.

  1997cited by this paper
• Role of actin in regulation of epithelial sodium channels by CFTR.

  1997cited by this paper
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

  1997cited by this paper
• Differential Effects of Protein Kinase C, Ras, and Raf-1 Kinase on the Induction of the Cardiac B-type Natriuretic Peptide Gene through a Critical Promoter-proximal M-CAT Element*

  1997cited by this paper
• Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.

  1996cited by this paper
• Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.

  1996cited by this paper
• Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.

  1996cited by this paper
• Natriuretic peptide responses to acute and chronic ventricular pacing in sheep.

  1996cited by this paper
• Natriuretic hormones.

  1995cited by this paper
• Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

  1995cited by this paper
• Time-dependent decreases of atrial natriuretic peptide release from the isolated rat atrium: evidence for a readily releasable pool.

  1995cited by this paper
• Biochemistry of natriuretic peptides

  1994cited by this paper
• Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes.

  1994cited by this paper
• Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro.

  1993cited by this paper
• Stretch-induced atrial natriuretic factor release utilizes a rapidly depleting pool of newly synthesized hormone.

  1993cited by this paper
• Rat brain natriuretic peptide is localized in atrial granules and released into the circulation.

  1992cited by this paper
• Atrial natriuretic peptide: synthesis, release, and metabolism.

  1992cited by this paper
• Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis.

  1992cited by this paper
• Deconvolution analysis of hormone data.

  1992cited by this paper
• Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes.

  1991cited by this paper
• A decade of atrial natriuretic factor research.

  1991cited by this paper
• Ovine atrial natriuretic factor: sequence of circulating forms and metabolism in plasma.

  1991cited by this paper
• Light and Electron Microscopic Localization of Brain Natriuretic Peptide in Relation to Atrial Natriuretic Peptide in Porcine Atrium: Immunohistocytochemical Study Using Specific Monoclonal Antibodies

  1991cited by this paper
• Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

  1989cited by this paper
• Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man.

  1988cited by this paper
• NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life.

  1988cited by this paper
• Secretion of atrial natriuretic factor-(1-98) by primary cardiac myocytes.

  1988cited by this paper
• Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP.

  1988cited by this paper
• γ-Atrial natriuretic polypeptide (γANP)-derived peptides in human plasma: Cosecretion of N-terminal γANP fragment and αANP

  1988cited by this paper
• Physiological role of silent receptors of atrial natriuretic factor.

  1987cited by this paper
• Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasma.

  1987cited by this paper
• The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations.

  1987cited by this paper
• The pituitary gland secretes in bursts

  1987cited by this paper
• Identification of a biologically active circulating form of rat atrial natriuretic factor.

  1985cited by this paper

• Assessing Established Diagnostic Markers of HFpEF in Older Patients Presenting with Acute Dyspnoea in the Emergency Department

  2025cites this paper
• Validation of N-Terminal Pro B-Type Natriuretic Peptide Threshold for Early Detection of Pre-Heart Failure in a General Japanese Population　- Toon Health Study.

  2025cites this paper
• Construction and validation of a personalized risk prediction model for in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention

  2025cites this paper
• Investigating the diagnostic accuracy of vertebral heart score, vertebral left atrium score and thoracic width measurement in cats with suspected cardiac problems

  2025cites this paper
• Carbohydrate antigen 125 (CA125) following acute myocardial infarction: effects of empagliflozin and association with heart failure readouts in the EMMY trial

  2025cites this paper
• Elevation of cardiac enzymes and B-type natriuretic peptides following venous recanalization and stenting in chronic venous obstruction

  2024cites this paper
• The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes

  2024cites this paper
• Cardiac natriuretic peptides.

  2024cites this paper
• Bad players in AL amyloidosis in the current era of treatment

  2023cites this paper
• The Predictive Value of A, B, and C-Type Natriuretic Peptides in People at Risk of Heart Disease: Protocol for a Longitudinal Observational Study

  2023cites this paper
• Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC

  2023cites this paper
• New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models

  2023cites this paper
• Animal Models to Study Cardiac Arrhythmias

  2022cites this paper
• Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction

  2022cites this paper
• A State of Natriuretic Peptide Deficiency

  2022cites this paper
• Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.

  2022cites this paper
• Elevated N-terminal pro-brain-type natriuretic peptide at admission is associated with unfavorable outcomes after aneurysmal subarachnoid hemorrhage.

  2022cites this paper
• Usefulness of the B-Type Natriuretic Peptides in Low Ejection Fraction, Low-Flow, Low-Gradient Aortic Stenosis Results from the TOPAS Multicenter Prospective Cohort Study

  2021cites this paper
• Role of NT-proBNP in Detection of Left Ventricular Diastolic Dysfunction in Asymptomatic Type 2 Diabetes Patients with Preserved Ejection Fraction: A Cross-sectional Study

  2021cites this paper
• Increases in NT-proBNP in the poisoned patient are probably multifactorial

  2021cites this paper
• NT Pro‐BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement

  2021cites this paper
• Blood parameters as a measure for controlling physical performance of young Algerian cyclists (U23 category)

  2021cites this paper
• Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.

  2020cites this paper
• Influence of aging on deterioration of patients with COVID-19

  2020cites this paper
• Biochemical markers after the Norseman Extreme Triathlon

  2020cites this paper
• Transthoracic echocardiography and cardiac biomarkers in healthy captive male and female squirrel monkeys (Saimiri spp.)

  2020cites this paper
• Natriuretic peptides as the basis of peptide drug discovery for cardiovascular diseases.

  2020cites this paper
• Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world.

  2020cites this paper
• Biomarkers of Drug Toxicity and Safety Evaluation

  2019cites this paper
• Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism

  2019cites this paper
• Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Biomarkers.

  2019cites this paper
• Successful Management of Pulmonary Arterial Hypertension by Monitoring N-Terminal Pro-B-Type Natriuretic Peptide Serum Levels in a Preterm Infant with Chronic Lung Disease: A Case Report

  2019cites this paper
• Establishment of normal reference values of NT-proBNP and its application in diagnosing acute heart failure in children with severe hand food and mouth disease

  2018cites this paper
• Usefulness of the MrWALLETS Scoring System to Predict First Diagnosed Atrial Fibrillation in Patients With Ischemic Stroke.

  2017cites this paper
• Cardiac Natriuretic Peptides

  2017cites this paper
• Natriuretic Peptides and Analytical Barriers.

  2017cites this paper
• N-terminal Pro-brain Natriuretic Peptide in Apparently Healthy Smokers.

  2017cites this paper
• Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats

  2017cites this paper
• A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.

  2017cites this paper
• Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

  2016cites this paper
• The Endocrine Heart

  2016cites this paper
• Use of Electrocardiography to Predict Future Development of Hypertension in the General Population

  2016cites this paper
• Natriuretic Peptides and Cardiovascular Events

  2016cites this paper
• Analytical Issues with Natriuretic Peptides – has this been Overly Simplified?

  2016cites this paper
• B-type natriuretic peptide signal peptide (BNPsp) in patients presenting with chest pain.

  2016cites this paper
• P mino-Terminal ProB-Type atriuretic Peptide and B-Type atriuretic Peptide in the General Community eterminants and Detection of Left Ventricular Dysfunction

  2016cites this paper
• The application of cardiac biomarkers as detectors for cardiac disease in horses

  2015cites this paper
• B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues.

  2015cites this paper
• Clinical value of natriuretic peptides in chronic kidney disease.

  2015cites this paper
• Heart failure in elderly with focus on diagnosis and prognosis

  2015cites this paper
• Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.

  2015cites this paper
• Cardiac biomarkers in children with congenital heart disease

  2015cites this paper
• Equine BNP measurement using a porcine BNP enzyme-linked immunoassay: a pilot study

  2015cites this paper
• Circulating Biomarkers for Drug‐Induced Cardiotoxicity: Reverse Translation from Patients to Nonclinical Species

  2015cites this paper
• Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension.

  2015cites this paper
• Analyse van equine BNP met een porciene BNP "enzyme-linked immunoassay": een pilootstudie

  2015cites this paper
• Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.

  2014cites this paper
• Brain natriuretic peptide: a biomarker for all cardiac disease?

  2014cites this paper
• The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects

  2014cites this paper
• Prognostic Significance of B Type Natriuretic Peptide in Acute Coronary Syndrome

  2014cites this paper
• Biomarkers in drug safety evaluation

  2014cites this paper
• The heart as an endocrine organ

  2014cites this paper
• Changes of natriuretic peptides concentration in early phase of acute myocardial infarction.

  2014cites this paper
• Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research

  2014cites this paper
• Breed Differences in Natriuretic Peptides in Healthy Dogs

  2014cites this paper
• Natriuretic peptides in heart failure and acute coronary syndrome.

  2014cites this paper
• Asymmetric Dimethylarginine and Pro-B-Type Natriuretic Peptide Levels in Patients With Carbon Monoxide Poisoning

  2013cites this paper
• NTproBNP: an important biomarker in cardiac diseases.

  2013cites this paper
• Assessment of coronary artery disease by computed tomography

  2013cites this paper
• Heart Failure Biomarkers

  2013cites this paper
• Facteurs diagnostiques et pronostiques dans l'insuffisance cardiaque aiguë

  2013cites this paper
• Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease.

  2013cites this paper
• N-terminal prohormone B-type natriuretic peptide and weaning outcome in postoperative patients with pulmonary complications

  2013cites this paper
• NT-proBNP, C-Reactive Protein and Soluble uPAR in a Bi-Ethnic Male Population: The SAfrEIC Study

  2013cites this paper
• Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.

  2013cites this paper
• Human and equine cardiovascular endocrinology: beware to compare

  2013cites this paper
• Serum NT‐proBNP in the early detection of doxorubicin‐induced cardiac dysfunction

  2013cites this paper
• NTproBNP as a marker of rejection in pediatric heart transplant recipients

  2012cites this paper
• B-type natriuretic peptide: from posttranslational processing to clinical measurement.

  2012cites this paper
• Association of cardiac and renal function with extreme N-terminal fragment Pro-B-type natriuretic peptide levels in elderly patients

  2012cites this paper
• Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.

  2012cites this paper
• N–terminal prohormone B–type natriuretic peptide, inflammation and the vasculature : exploring the links in a bi–ethnic South African population

  2012cites this paper
• Correlation of N-terminal fragment of B-type natriuretic peptide levels with clinical, laboratory, and echocardiographic abnormalities in children with sickle cell disease.

  2012cites this paper
• IntErés DE los PéPtIDos natrIurétIcos En carDIología VEtErInarIa

  2012cites this paper
• Postmortem Biochemistry (I) : Cardiac Markers

  2012cites this paper
• N-terminal prohormone B-type natriuretic peptide and cardiovascular function in Africans and Caucasians: the SAfrEIC study.

  2012cites this paper
• NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure

  2012cites this paper
• NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study.

  2012cites this paper
• NT-proBNP bei der Dilatativen Kardiomyopathie des Dobermanns: Erstellung von Referenzwerten und Durchführung eines Testvergleichs sowie einer Follow-Up-Studie

  2012cites this paper
• Biomarkers in acute respiratory failure

  2012cites this paper
• The biochemical aspects of a non-ST-segment elevation acute coronary syndrome.

  2012cites this paper
• Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance

  2011cites this paper
• Novel biomarkers in human terminal heart failure and under mechanical circulatory support

  2011cites this paper
• N-terminal pro-B-type natriuretic peptide with fractional excretion and clearance of sodium in relation to cardiovascular events after elective cervical spine surgery.

  2011cites this paper
• Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing.

  2011cites this paper
• N-terminal pro-B-type natriuretic peptide and diastolic function measurements by adenosine stress echocardiography in prediction of coronary stenosis in patients.

  2011cites this paper
• N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.

  2011cites this paper
• Human pro-B-type natriuretic peptide is processed in the circulation in a rat model.

  2011cites this paper
• B-type natriuretic peptides for prediction and diagnosis of weaning failure from cardiac origin

  2011cites this paper
• N‐terminal‐pro‐BNP in critically ill patients with acute respiratory failure: a prospective cohort study

  2011cites this paper